Jump to content
  • Sign Up

Archived

This topic is now archived and is closed to further replies.

Scott Adams

Deal Watch: Abbvie Invests In Pioneering Celiac Disease Therapy - Nature.com

Recommended Posts

Deal watch: AbbVie invests in pioneering celiac disease therapy

Nature.com

AbbVie and Alvine Pharmaceuticals have teamed up to develop ALV003, which is a novel oral treatment that is currently in Phase II development for patients with celiac disease. Under the terms of the agreement, AbbVie will make an initial upfront ...

View the full article

Share this post


Link to post
Share on other sites

×
×
  • Create New...